These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12819802)

  • 41. Molecule of the month. ACE2: an attractive new target for cardiovascular drug discovery.
    Drug News Perspect; 2001 Mar; 14(2):122. PubMed ID: 12819802
    [No Abstract]   [Full Text] [Related]  

  • 42. ACE2: A novel therapeutic target for cardiovascular diseases.
    Der Sarkissian S; Huentelman MJ; Stewart J; Katovich MJ; Raizada MK
    Prog Biophys Mol Biol; 2006; 91(1-2):163-98. PubMed ID: 16009403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physiological roles of angiotensin-converting enzyme 2.
    Danilczyk U; Eriksson U; Oudit GY; Penninger JM
    Cell Mol Life Sci; 2004 Nov; 61(21):2714-9. PubMed ID: 15549172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist.
    Santos RA; Ferreira AJ
    Cardiovasc Drug Rev; 2006; 24(3-4):239-46. PubMed ID: 17214600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The target discovery process.
    Egner U; Krätzschmar J; Kreft B; Pohlenz HD; Schneider M
    Chembiochem; 2005 Mar; 6(3):468-79. PubMed ID: 15742383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin-converting enzyme II in the heart and the kidney.
    Danilczyk U; Penninger JM
    Circ Res; 2006 Mar; 98(4):463-71. PubMed ID: 16514079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The importance of ACE2 in regulating the cardiovascular system].
    Raz A; Gamliel-Lazarovich A; Bogner I; Strigevsky A; Keidar S
    Harefuah; 2007 Sep; 146(9):703-6, 733. PubMed ID: 17969309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A chemogenomic approach to drug discovery: focus on cardiovascular diseases.
    Cases M; Mestres J
    Drug Discov Today; 2009 May; 14(9-10):479-85. PubMed ID: 19429507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment.
    Showalter HD; Denny WA
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S3-17. PubMed ID: 18762151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fishing for new antimicrobials.
    Mukhopadhyay A; Peterson RT
    Curr Opin Chem Biol; 2006 Aug; 10(4):327-33. PubMed ID: 16822704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology.
    Dunlop J; Bowlby M; Peri R; Vasilyev D; Arias R
    Nat Rev Drug Discov; 2008 Apr; 7(4):358-68. PubMed ID: 18356919
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.